Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. (Q54479081)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. |
scientific article |
Statements
Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. (English)
1 reference
1 reference
Sara Redaelli
1 reference
Luca Mologni
1 reference
Roberta Rostagno
1 reference
Rocco Piazza
1 reference
Monica Ceccon
1 reference
Michela Viltadi
1 reference
Daniel Flynn
1 reference
9 October 2012
1 reference
87
1 reference
11
1 reference
E125-8
1 reference
Identifiers
1 reference